TrialDrug design, development and therapy2020

Apatinib in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: A Phase II, Open-Label, Single-Arm, Prospective Study.

Xinran Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.